Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...
Moderna , Inc. (NASDAQ:MRNA) today confirmed that it has won a tender to supply its mRNA COVID-19 vaccine in the European Union (EU), Norway, and North Macedonia. The agreement, valid for up to four ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
Why Goldman Cut Its Rating on MRNA Earlier this month, Moderna reduced its 2025 revenue ... the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe ...
Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four ...
As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...
The primary endpoint of the trial is disease-free survival (DFS) with an overall follow-up period of up to 78 months ... its worth in the COVID-19 pandemic. Moderna’s arch-rival in the mRNA ...
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
Obtained by NY Post Scott allegedly launched into his new robbery spree just over a month later — going on to steal electronics and other loot from 19 businesses all on the southern end of the ...